Flexan, a portfolio company of Linden Capital Partners since February 2015, has acquired IntroMed, a contract manufacturer of patented sheath introducers.
Sheath introducers are long and wide bore catheters through which various other vascular catheters can be inserted. These products act as a “sheath” around these other catheters, providing a clean path and protected portal for these catheters to enter a blood vessel. IntroMed was founded in 2005 by Ron Wortley and is headquartered in Salt Lake City.
Flexan is an outsourced manufacturer of silicone, rubber, and thermoplastic components that are primarily used in medical devices but also in hearing technology, miniature pneumatics, industrial controls, and aerospace and defense products. The company, led by President & CEO Jim Fitzgerald and headquartered in Lincolnshire, IL, has manufacturing facilities in Chicago and Elk Grove Village, IL; Salt Lake City, UT; and Suzhou, China (www.flexan.com).
“We are excited to add IntroMed’s capabilities and technology to our array of contract manufacturing services,” said Mr. Fitzgerald. “Similar to the acquisition of Medron, IntroMed has a reputation for providing innovative, high-quality products and components to medical device OEMs.” Flexan acquired Medron, a contract manufacturer of catheters and endoscopy products, from Mr. Wortley in December 2016.
“The addition of IntroMed enhances our contract manufacturing service offering as part of our continued focus on investing in and expanding the services we offer our global customer base,” said Ron Labrum, a Linden Operating Partner.
Linden Capital Partners is focused exclusively on leveraged buyouts in the healthcare and life science industries with a specific interest in medical products, specialty distribution, pharmaceutical, and services segments of healthcare. Linden’s strategy is based on three elements: healthcare and life science industry specialization; integrated financial and operating expertise; and strategic relationships with large corporations. The firm is based in Chicago (www.lindenllc.com).
© 2018 Private Equity Professional | April 17, 2018
